Health Holland Research Grant Awarded

Aug 8, 2019

Funding for a 2-year research collaboration entitled “Improved personalized vaccines against cancer: quality of T cell immunity matters” has been awarded by Health Holland.

In this project Immunetune will collaborate with Leiden University Medical Center to further optimize cancer vaccines by inclusion of specific CD4 helper epitopes.

Biotech Wednesday: Joining forces to outsmart cancer

Biotech Wednesday: Joining forces to outsmart cancer

Immunetune will be attending Biotech Wednesday on November 20 in Utrecht, the Netherlands. Reach out to us through the networking app or contact us directly in case you'd like to learn more about Immunetune's approach to fight cancer. More information on this meeting...

read more
Neoantigen Summit, 20-22 Nov in Boston

Neoantigen Summit, 20-22 Nov in Boston

CSO Jeroen van Bergen will be presenting key highlights of Immunetune's preclinical proof-of-concept results at the Neoantigen summit in Boston, USA on November 20-22, 2019.

read more